Advertisement

Topics

Advanced in vitro cell technologies, s.l. Company Profile

18:59 EDT 24th September 2017 | BioPortfolio

ADVANCELL has 3 different operational sites in Spain: Barcelona, Valencia and Galicia (see map)ADVANCELL´s headquarters are located in Barcelona (Barcelona Science Park)
Corporate growth and consolidation have been achieved by merging scientific expertise with business-oriented management principles.

Location

Parc Científic de Barcelona
Baldiri Reixac, 10-12
Barcelona
08028
Spain

Contact

Phone: (34) 93.403.45.45
Fax: 34) 93.403.45.44
Email: advancell@advancell.net


News Articles [4353 Associated News Articles listed on BioPortfolio]

HemoGenix Licenses Assays and Reagents to Preferred Cell Systems

Colorado Springs, CO – HemoGenix, Inc. is pleased to announce that it has licensed the manufacturing, sales and marketing of its proprietary reagents and in vitro assay kits to Preferred Cell Sy...

Advanced Enzymes acquires evoxx

The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a...

Advanced Enzyme Technologies Buys Evoxx

Indian enzyme manufacturer Advanced Enzyme Technologies has announced it will acquire all of German industrial biotech company Evoxx Technologies for €7.65 million in a bid to expand its enzyme p...

Immunotherapy Safely Treats Advanced Squamous Cell Carcinoma

An anti–PD-1 monoclonal antibody is safe and effective for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.

Opdivo in Combination with Yervo Demonstrates Improved Overall Survival for Advanced Renal Cell Carcinoma

A Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) in patients with previously untreated advanced or metastatic renal cell […] The post Opdivo in Combination with Yervo Demon...

'Exquisite selectivity' of neuronal wiring in the cerebral cortex revealed by research

Advanced technologies has been used to illuminate the connectivity pattern of chandelier cells, a distinctive kind of inhibitory cell type in the mammalian brain. Scientists reveal for the first time ...

Mesenchymal Stem Cells Relevance in Multicellular Bioengineered 3D In vitro Tumor Models

In vitro 3D tumor microenvironment mimicking models are gathering momentum as alternatives to traditional 2D flat monolayer cultures due to their potential for recapitulating major cancer hallmarks. T...

Cancer Precision Immunotherapy Combination of Epacadostat plus Keytruda® Demonstrates Promise in Advanced Non-Small Cell Lung Cancer

Updated data from the advanced non-small cell lung cancer (NSCLC) group of an ongoing clinical trial evaluating epacadostat combined with […] The post Cancer Precision Immunotherapy Combination ...

PubMed Articles [10910 Associated PubMed Articles listed on BioPortfolio]

Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications.

In this review, we introduce current developments in induced pluripotent stem cells (iPSCs), site-specific nuclease (SSN)-mediated genome editing tools, and the combined application of these two novel...

In Vitro Differentiation and Propagation of Urothelium from Pluripotent Stem Cell Lines.

Bioengineering of bladder tissue, particularly for those patients who have advanced bladder disease, requires a source of urothelium that is healthy, capable of significant proliferation in vitro and ...

Advanced biomaterials and microengineering technologies to recapitulate the stepwise process of cancer metastasis.

Cancer is one of the leading causes of death globally according to the World Health Organization. Although improved treatments and early diagnoses have reduced cancer related mortalities, metastatic d...

3D Miniaturization of Human Organs for Drug Discovery.

"Engineered human organs" hold promises for predicting the effectiveness and accuracy of drug responses while reducing cost, time, and failure rates in clinical trials. Multiorgan human models utilize...

Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).

Cytokine-induced killer (CIK) cells have important therapeutic effects in adoptive cell transfer (ACT) for the treatment of various malignancies. In this study, we focused on in vitro expansion of CIK...

Clinical Trials [9925 Associated Clinical Trials listed on BioPortfolio]

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Establishment of Comprehensive Genetic Analysis From a Single Cell

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and redu...

In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients

Peripheral blood mononuclear cells (PBMC) will be collected from patients who have leukemia or lymphoma or other medical conditions involving altered lymphohematopoietic stem cell or immun...

In Vitro Maturation With in Vitro Fertilization (IVF) Compared to Mild in Vitro Fertilization

Methods of infertility treatment may involve in vitro fertilization or IVF. Though effective, IVF is complex and expensive. Methods using no gonadotropin hormone stimulation of the ovaries...

Multiple Target Antigen Stimulating Cell Therapy (MASCT-I) Treatment for Advanced Evil Solid Tumor

Multiple Target Antigen Stimulating Cell Therapy (MASCT-I) is a new immunotherapy that dendritic cells(DC) was induced from autologous peripheral blood. The DC can then be loaded with anti...

Companies [3240 Associated Companies listed on BioPortfolio]

Vitro Diagnostics, Inc.

Vitro Diagnostics, Inc., dba Vitro Biopharma (OTCBB: VODG) (http://www.vitrobiopharma.com), owns U.S. patents for production of a fertility drug, immortalization of pituitary cell...

Chip-Man Technologies Ltd

Chip-man Technolgies was formed in 2002 from researchers from the University of Tampere, Technical University of Tampere and the Finnish Research Organisation, VTT. The founders combined expertise to ...

Advanced in vitro cell technologies, s.l.

ADVANCELL has 3 different operational sites in Spain: Barcelona, Valencia and Galicia (see map)ADVANCELL´s headquarters are located in Barcelona (Barcelona Science Park)Corporate growth and consolida...

HemoGenix, Inc.

HemoGenix® is a privately-held Contract Research Service and Assay Development Laboratory based in Colorado Springs, Colorado. Specializing in predictive in vitro stem cell tox...

In Vitro Technologies

About Celsis In Vitro Technologies Increasing discovery. Advancing development. Leading provider of In Vitro and ADME-Tox Products. Celsis In Vitro Technologies (IVT) provides high quality, value-add...

More Information about "Advanced in vitro cell technologies, s.l." on BioPortfolio

We have published hundreds of Advanced in vitro cell technologies, s.l. news stories on BioPortfolio along with dozens of Advanced in vitro cell technologies, s.l. Clinical Trials and PubMed Articles about Advanced in vitro cell technologies, s.l. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced in vitro cell technologies, s.l. Companies in our database. You can also find out about relevant Advanced in vitro cell technologies, s.l. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record